Daniel Leblanc

Daniel LeBlanc is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as a Senior Quality Control Analyst at TScan Therapeutics since May 2023. With a strong background in quality control and scientific research, Daniel has previously held positions such as Senior Associate Scientist at Pfizer from April 2021 to May 2023, and Sr. Research Associate at Editas from November 2018 to February 2021. Daniel's expertise includes conducting a variety of assays related to vaccine drug products and independently designing laboratory experiments. Daniel also has experience at Moderna, Takeda, OvaScience, PerkinElmer, Toxikon Corporation, Arisaph Pharmaceuticals, and Beth Israel Deaconess Medical Center, where responsibilities encompassed process development, safety testing, and cell culture services. Daniel obtained a Bachelor of Science in Biology from UMass Boston from 1997 to 2001.